1. Home
  2. EW vs HLN Comparison

EW vs HLN Comparison

Compare EW & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Edwards Lifesciences Corporation

EW

Edwards Lifesciences Corporation

HOLD

Current Price

$91.49

Market Cap

48.9B

Sector

Health Care

ML Signal

HOLD

Logo Haleon plc (Each representing two)

HLN

Haleon plc (Each representing two)

HOLD

Current Price

$9.73

Market Cap

44.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
EW
HLN
Founded
1958
2022
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Industrial Specialties
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
48.9B
44.5B
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
EW
HLN
Price
$91.49
$9.73
Analyst Decision
Buy
Buy
Analyst Count
21
1
Target Price
$96.37
N/A
AVG Volume (30 Days)
4.3M
10.3M
Earning Date
04-23-2026
02-26-2026
Dividend Yield
N/A
1.94%
EPS Growth
N/A
N/A
EPS
1.07
N/A
Revenue
$6,067,600,000.00
N/A
Revenue This Year
$13.39
$6.55
Revenue Next Year
$9.81
$4.42
P/E Ratio
$84.87
$49.05
Revenue Growth
11.55
N/A
52 Week Low
$72.30
$8.65
52 Week High
$96.29
$11.28

Technical Indicators

Market Signals
Indicator
EW
HLN
Relative Strength Index (RSI) 57.37 47.20
Support Level $81.19 $9.62
Resistance Level $93.91 $10.03
Average True Range (ATR) 1.90 0.14
MACD 0.36 -0.06
Stochastic Oscillator 71.07 26.67

Price Performance

Historical Comparison
EW
HLN

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: